Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sherine N Khattab

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Venues

Nanomedicine (London, England)

ACS omega

ChemMedChem

Biomacromolecules

Alexandria University Faculty of Science

Alexandria University Faculty of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Alexandria University Faculty of Science Nov 1o 2012

Egypt

Professor of Organic and Peptide Chemistry :: Chemistry

Education History

Alexandria University Faculty of Science Jul 1o 1995 - Oct 1o 2000

Egypt

PHD :: Chemistry

Publications

Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) (2023)
Yomna M Elmorshedy, Mohamed Teleb, Marwa A Sallam, Kadria A Elkhodairy, Mohammed Bahey-El-Din, Doaa Ahmad Ghareeb, Shaymaa A Abdulmalek, Shimaa A H Abdel Monaim, Adnan A Bekhit, Ahmed O Elzoghby, Fernando Albericio, Sherine N Khattab
Engineered Microencapsulated Lactoferrin Nanoconjugates for Oral Targeted Treatment of Colon Cancer. Biomacromolecules (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Riham M Abdelgalil, Sherine N Khattab, Shaker Ebrahim, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Marwa A Sallam, Ahmed O Elzoghby
Engineered Sericin-Tagged Layered Double Hydroxides for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible Cancer Nanotheranostics. ACS omega 8 (6) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Riham M Abdelgalil, Sherine N Khattab, Shaker Ebrahim, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Marwa A Sallam, Ahmed O Elzoghby
Engineered Sericin-Tagged Layered Double Hydroxides for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible Cancer Nanotheranostics. ACS omega 8 (6) (2023)
Nesreen S Haiba, Hosam H Khalil, Ahmed Bergas, Marwa M Abu-Serie, Sherine N Khattab, Mohamed Teleb
First-in-Class Star-Shaped Triazine Dendrimers Endowed with MMP-9 Inhibition and VEGF Suppression Capacity: Design, Synthesis, and Anticancer Evaluation. ACS omega 7 (24) (2022)
Mai Salah, Marwa A Sallam, Mona A Abdelmoneem, Mohamed Teleb, Kadria A Elkhodairy, Adnan A Bekhit, Asmaa F Khafaga, Ahmed E Noreldin, Ahmed O Elzoghby, Sherine N Khattab
Sequential Delivery of Novel Triple Drug Combination via Crosslinked Alginate/Lactoferrin Nanohybrids for Enhanced Breast Cancer Treatment. Pharmaceutics 14 (11) (2022)
Nehad Noby, Rachel L Johnson, Jonathan D Tyzack, Amira M Embaby, Hesham Saeed, Ahmed Hussein, Sherine N Khattab, Pierre J Rizkallah, D Dafydd Jones
Structure-Guided Engineering of a Family IV Cold-Adapted Esterase Expands Its Substrate Range. International journal of molecular sciences 23 (9) (2022)
Dina A Hafez, Islam A Hassanin, Mohamed Teleb, Sherine N Khattab, Kadria A Elkhodairy, Ahmed O Elzoghby
Recent advances in nanomedicine-based delivery of histone deacetylase inhibitors for cancer therapy. Nanomedicine (London, England) 16 (25) (2021)
Doaa M Anwar, Mousa El-Sayed, Asmaa Reda, Jia-You Fang, Sherine N Khattab, Ahmed O Elzoghby
Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes. Expert opinion on drug delivery 18 (11) (2021)
Hosam H Khalil, Heba A Osman, Mohamed Teleb, A I Darwish, Marwa M Abu-Serie, Sherine N Khattab, Nesreen S Haiba
Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma. ChemMedChem (2021)
Nayra M Kamel, Maged W Helmy, Elsayeda-Zeinab Abdelfattah, Sherine N Khattab, Doaa Ragab, Magda W Samaha, Jia-You Fang, Ahmed O Elzoghby
Inhalable Dual-Targeted Hybrid Lipid Nanocore-Protein Shell Composites for Combined Delivery of Genistein and All-Trans Retinoic Acid to Lung Cancer Cells. ACS biomaterials science & engineering 6 (1) (2019)
Sherine N Khattab, Hosam H Khalil, Adnan A Bekhit, Mohamed M Abd El-Rahman, Beatriz G de la Torre, Matti Haukka, Fernando Albericio
1,3,5-Triazino Peptide Derivatives: Synthesis, Characterization, and Preliminary Antileishmanial Activity. ChemMedChem 13 (7) (2018)
Doaa M Anwar, Sherine N Khattab, Maged W Helmy, Mohamed K Kamal, Adnan A Bekhit, Kadria A Elkhodairy, Ahmed O Elzoghby
Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma. Bioconjugate chemistry 29 (9) (2018)

Sherine N Khattab.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sherine N Khattab